Patrizio Mattei

Jul 11, 2024 | nature.com | Claudia Zampaloni |Patrizio Mattei |Christian H. Bucher |Alexander Alanine |Vadim Baidin |Franziska Boess | +14 more

Correction to: Nature https://doi.org/10.1038/s41586-023-06873-0 Published online 3 January 2024In the version of the article initially published, three references were missing and have now been added as refs. 20–22: Schuster, M. et al. Peptidomimetic antibiotics disrupt the lipopolysaccharide transport bridge of drug-resistant Enterobacteriaceae. Sci. Adv. 9, eadg3683 (2023); Martin-Loeches, I., Dale, G. E. & Torres, A. Murepavadin: a new antibiotic class in the pipeline. Expert Rev. Anti-infect. Ther.